<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-08T16:12:48Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/35418" metadataPrefix="oai_dc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/35418</identifier><datestamp>2026-02-03T11:23:33Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37953</setSpec></header><metadata><oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice.</dc:title>
   <dc:creator>Skelton, Jessica Katy</dc:creator>
   <dc:creator>Ortega-Prieto, Ana María</dc:creator>
   <dc:creator>Kaye, Steve</dc:creator>
   <dc:creator>Jimenez-Guardeño, Jose Manuel</dc:creator>
   <dc:creator>Turner, Jane</dc:creator>
   <dc:creator>Malim, Michael H.</dc:creator>
   <dc:creator>Towers, Greg J.</dc:creator>
   <dc:creator>Dorner, Marcus</dc:creator>
   <dc:subject>Virología - Investigación</dc:subject>
   <dc:subject>Virus del SIDA</dc:subject>
   <dc:subject>Modelos animales en investigación</dc:subject>
   <dc:subject>SIDA - Modelos animales</dc:subject>
   <dc:subject>Virology</dc:subject>
   <dc:subject>Virus</dc:subject>
   <dc:subject>HIV</dc:subject>
   <dc:description>Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chronic phases of HIV-1 infection in humanized mice. We show that very early in infection, HIV-1 suppresses peripheral type I interferon (IFN) and interferon-stimulated gene (ISG) responses, including the HIV-1 restriction factor IFI44. At the peak of innate immune activation, prior to CD4 T cell loss, HIV-1 infection differentially affects peripheral and lymphoid Toll-like receptor (TLR) expression profiles in T cells and macrophages. This results in a trend toward an altered activation of nuclear factor κB (NF-κB), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3). The subsequent type I and III IFN responses result in preferential induction of peripheral ISG responses. Following this initial innate immune activation, peripheral expression of the HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1) returns to levels below those observed in uninfected mice, suggesting that HIV-1 interferes with their basal expression. However, peripheral cells still retain their responsiveness to exogenous type I IFN, whereas splenic cells show a reduction in select ISGs in response to IFN. This demonstrates the highly dynamic nature of very early HIV-1 infection and suggests that blocks to the induction of HIV-1 restriction factors contribute to the establishment of viral persistence</dc:description>
   <dc:date>2024-12-02T10:33:42Z</dc:date>
   <dc:date>2024-12-02T10:33:42Z</dc:date>
   <dc:date>2019-05-15</dc:date>
   <dc:type>journal article</dc:type>
   <dc:type>VoR</dc:type>
   <dc:identifier>Skelton JK, Ortega-Prieto AM, Kaye S, Jimenez-Guardeño JM, Turner J, Malim MH, Towers GJ, Dorner M.2019.Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice. J Virol93:10.1128/jvi.02123-18.https://doi.org/10.1128/jvi.02123-18</dc:identifier>
   <dc:identifier>https://hdl.handle.net/10630/35418</dc:identifier>
   <dc:identifier>10.1128/JVI.02123-18</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>ASM Journals</dc:publisher>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>